BRPI0820520B8 - processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos - Google Patents

processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos

Info

Publication number
BRPI0820520B8
BRPI0820520B8 BRPI0820520A BRPI0820520A BRPI0820520B8 BR PI0820520 B8 BRPI0820520 B8 BR PI0820520B8 BR PI0820520 A BRPI0820520 A BR PI0820520A BR PI0820520 A BRPI0820520 A BR PI0820520A BR PI0820520 B8 BRPI0820520 B8 BR PI0820520B8
Authority
BR
Brazil
Prior art keywords
drugs
release
manufacture
products
dosage forms
Prior art date
Application number
BRPI0820520A
Other languages
English (en)
Inventor
Coffee Michael
E Paulsen Neil
Johnson Roland
Original Assignee
Piedmont Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40639740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0820520(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Piedmont Pharmaceuticals Llc filed Critical Piedmont Pharmaceuticals Llc
Publication of BRPI0820520A2 publication Critical patent/BRPI0820520A2/pt
Publication of BRPI0820520B1 publication Critical patent/BRPI0820520B1/pt
Publication of BRPI0820520B8 publication Critical patent/BRPI0820520B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos. a presente invenção refere-se a um veículo de medicação mastigável macio comestível palatável para a liberação de um ingrediente ativo farmaceuticaamente aceitável tal como um fármaco a um animal ou ser humano. os mastigáveis macios comestíveis contêm apenas ingredientes de grau alimentício, ou melhor, inativos, e preferivelmente não contêm ingredientes de origem animal. os processos para a fabricação dos mastigáveis macios comestíveis não requerem o uso de calor ou adição de água durante a mistura de ingredientes ativos e inativos, fornecem concentrações estáveis do ingrediente ativo, e produzem mastigáveis de peso e textura consistentes.
BRPI0820520A 2007-11-14 2008-11-13 processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos BRPI0820520B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/940,106 2007-11-14
US11/940,106 US7955632B2 (en) 2005-12-07 2007-11-14 Process for manufacturing chewable dosage forms for drug delivery and products thereof
PCT/US2008/083373 WO2009064859A1 (en) 2007-11-14 2008-11-13 Process for manufacturing chewable dosage forms for drug delivery and products thereof

Publications (3)

Publication Number Publication Date
BRPI0820520A2 BRPI0820520A2 (pt) 2017-05-23
BRPI0820520B1 BRPI0820520B1 (pt) 2020-10-06
BRPI0820520B8 true BRPI0820520B8 (pt) 2021-05-25

Family

ID=40639740

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820520A BRPI0820520B8 (pt) 2007-11-14 2008-11-13 processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos

Country Status (10)

Country Link
US (5) US7955632B2 (pt)
EP (2) EP2219626A4 (pt)
JP (1) JP2011503197A (pt)
CN (1) CN101909605B (pt)
AU (3) AU2008320992B2 (pt)
BR (1) BRPI0820520B8 (pt)
CA (1) CA2705724C (pt)
RU (1) RU2519670C2 (pt)
WO (1) WO2009064859A1 (pt)
ZA (2) ZA201003245B (pt)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014143A1 (en) * 2002-08-13 2004-02-19 Akzo Nobel Compositions and process for delivering an additive
US20070128251A1 (en) * 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
US9918489B2 (en) * 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
JP2013539772A (ja) * 2010-10-12 2013-10-28 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 非澱粉を基にしたソフトチュアブル
AU2012307656B2 (en) 2011-09-15 2016-07-07 Friulchem Spa Compositions for oral administration to animals, production methods thereof and uses of same
WO2013068371A1 (en) * 2011-11-08 2013-05-16 Intervet International B.V. Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists
AP2014007874A0 (en) 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
CN108685894B (zh) * 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
CN111803465B (zh) * 2013-03-15 2023-05-09 阿根塔创新有限公司 可咀嚼配制物
EP3137167A4 (en) 2014-04-29 2017-12-20 Colonaryconcepts LLC Foods, systems, methods, and kits for providing electrolyte replacement
EP3204044A4 (en) * 2014-10-07 2018-10-03 Andreas Voigt Micronized delivery material, method for manufacturing thereof and methods for application
JP2017533959A (ja) * 2014-11-03 2017-11-16 ゾエティス・サービシーズ・エルエルシー 嗜好性が高く咀嚼可能な獣医学的な組成物
WO2016130830A1 (en) 2015-02-11 2016-08-18 The Fix, Llc Compositions and methods for combination ingredient delivery
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
CN104996728A (zh) * 2015-08-21 2015-10-28 烟台中宠食品股份有限公司 一种软类宠物食品及其加工方法
EP3344238A4 (en) * 2015-09-01 2019-04-24 Colonaryconcepts LLC DEFLECTIVE FORMULATIONS AND MANUFACTURE
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CN108712900A (zh) 2015-12-19 2018-10-26 第时间美国泛型药物有限公司 软咀嚼片剂药物制剂
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
JP2019514991A (ja) 2016-05-12 2019-06-06 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ 動物に投与するための成型体の製造方法
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
AU2017330392B2 (en) * 2016-09-23 2021-08-05 Wm. Wrigley Jr. Company Stable flavor compositions containing mint leaves
US10898447B2 (en) 2016-10-27 2021-01-26 Psirrros Inc. Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use
US12329722B2 (en) 2016-10-27 2025-06-17 Psimos, Inc. Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
CN108926540A (zh) * 2017-05-25 2018-12-04 北京欧博方医药科技有限公司 一种用于制造药物递送的软咀嚼剂型的方法
CN110996920A (zh) 2017-07-26 2020-04-10 太杰先软嚼有限责任公司 用于兽医应用的无淀粉软咀嚼物
JP7412329B2 (ja) 2017-08-17 2024-01-12 セバ・サンテ・アニマル 経口用組成物及びその調製方法
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
US12194144B2 (en) 2018-09-22 2025-01-14 Florida Research Group Llc Soft chews with low water activity and methods of manufacturing same
CA3113902C (en) 2018-10-16 2021-12-21 Niacet Corporation Methods for fungi inhibition on live plants using carboxylic acids and their salts
EP4464335A3 (en) 2018-10-18 2025-03-05 Kenvue Brands LLC Novel dosage form
US20200129438A1 (en) * 2018-10-31 2020-04-30 Edenbridge Pharmaceuticals, LLC Finished pharmaceutical dosage form comprising a low dose/high potency active pharmaceutical ingredient and one or more excipients
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CN113438941A (zh) * 2019-02-20 2021-09-24 硕腾服务有限责任公司 可口制剂
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
WO2021046305A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions
EP3878436A1 (en) 2020-03-09 2021-09-15 Bayer Animal Health GmbH Soft chewable formed body for the administration to animals
WO2021190988A1 (en) * 2020-03-27 2021-09-30 Dsm Ip Assets B.V. Prenatal confectionery
US11707074B2 (en) 2020-04-09 2023-07-25 Kim Schwarz Edible hydration pod and method of manufacturing an edible hydration pod
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
US20220160628A1 (en) * 2020-11-24 2022-05-26 Florida Research Group Llc Process for manufacturing improved semi-soft solid dosage forms and soft chews produced thereby
GB202018694D0 (en) * 2020-11-27 2021-01-13 Nonwovenn Ltd Chewable product for oral delivery of a substance, and method of manufacturing the same
WO2022133420A1 (en) 2020-12-18 2022-06-23 Boehringer Ingelheim Animal Health USA Inc. Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof
DE102021116694B4 (de) * 2021-06-29 2023-03-09 Promocell Gmbh Wässrige Lösung zur Zellkonservierung
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3486186A (en) 1967-05-08 1969-12-30 Hollymatic Corp Molding apparatus
US3887964A (en) 1972-01-24 1975-06-10 Formax Inc Food patty molding machine
US3952478A (en) 1974-10-10 1976-04-27 Formax, Inc. Vacuum sheet applicator
US4054967A (en) 1975-10-20 1977-10-25 Formax, Inc. Food patty molding machine
US4284652A (en) 1977-01-24 1981-08-18 The Quaker Oats Company Matrix, product therewith, and process
US4182003A (en) 1978-02-28 1980-01-08 Formax, Inc. Food patty molding machine
US4182033A (en) * 1978-04-07 1980-01-08 The Gillette Company Scraper assembly
US4338702A (en) 1979-03-29 1982-07-13 Holly Harry H Apparatus for making a ground food patty
US4334339A (en) 1980-05-12 1982-06-15 Hollymatic Corporation Mold device with movable compression insert
US4356595A (en) 1980-11-07 1982-11-02 Formax, Inc. Method and apparatus for molding food patties
US4343068A (en) 1981-01-19 1982-08-10 Holly James A Method and apparatus for unidirectional formation of a plug-formed patty with cleanout feature
US4306883A (en) * 1981-01-29 1981-12-22 Gulf & Western Manufacturing Company Process for forming coal-oil mixtures under selected conditions of temperature and shear
US4372008A (en) 1981-04-23 1983-02-08 Formax, Inc. Food patty molding machine with multi-orifice fill passage and stripper plate
CH657506A5 (de) 1981-12-10 1986-09-15 Hollymatic Ag Portioniermaschine zum fuellen von hohlraeumen mit verformbarem material und verwendung derselben.
US4535505A (en) 1982-11-23 1985-08-20 Holly Systems, Inc. Method and apparatus for forming a patty to accommodate tissue fiber flow
US4608731A (en) 1983-01-11 1986-09-02 Holly Systems, Inc. Food patty with improved void structure, shape, and strength and method and apparatus for forming said patty
US4597135A (en) 1984-02-21 1986-07-01 Holly Systems, Inc. Food patty forming method and apparatus employing two or more agitator bars
CA1234717A (en) 1985-06-28 1988-04-05 Leslie F. Knebl Moist chewing gum composition
US4768941A (en) 1986-06-16 1988-09-06 Hollymatic Corporation Food patty and machine and method for making thereof
US4710390A (en) 1986-07-07 1987-12-01 Warner-Lambert Company Ingestible, high density, compressed-tablet fruit fiber composition
US4697308A (en) 1986-10-29 1987-10-06 Formax, Inc. Patty molding mechanism for whole fiber food product
DE3636882C1 (de) 1986-10-30 1988-05-19 Schreiber Berthold Vorrichtung zur feinblasigen Einleitung eines Gases in eine Fluessigkeit
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4780931A (en) 1987-02-13 1988-11-01 Marlen Research Corporation Feeding device for patty forming machine
US4821376A (en) 1988-06-02 1989-04-18 Formax, Inc. Seal-off for food patty molding machine with multi-orifice fill passage and stripper plate
US4997671A (en) 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US4872241A (en) 1988-10-31 1989-10-10 Formax, Inc. Patty molding mechanism for fibrous food product
US5021025A (en) 1989-09-12 1991-06-04 Wagner Richard C Method and machine for making food patties
US4975039A (en) 1989-09-18 1990-12-04 Dare Gary L Food molding and portioning apparatus
US4996743A (en) 1990-01-29 1991-03-05 Formax, Inc. Mold plate drive linkage
US5022888A (en) 1990-05-03 1991-06-11 Formax, Inc. Co-forming apparatus for food patty molding machine
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ES2202302T3 (es) 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US6352713B1 (en) 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5735603A (en) 1996-05-03 1998-04-07 Littleford Day, Inc. Horizontal mixer apparatus and method with improved shaft and seal structure
US5730650A (en) 1996-08-29 1998-03-24 Progressive Technology Of Wisconsin, Inc. Food patty molding machine
US5655436A (en) 1996-08-29 1997-08-12 Progressive Technology Of Manitowoc, Inc. Food patty molding machine
US5753255A (en) 1997-02-11 1998-05-19 Chavkin; Leonard Chewable molded tablet containing medicinally active substances
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6723714B2 (en) 1999-07-06 2004-04-20 Blansett Pharmacal Co., Inc. Aqueous solvent for corticosteroids
US6495177B1 (en) 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
CA2383578A1 (en) 1999-09-06 2001-03-15 Mars Uk Limited Food product and process for manufacturing same
US6340471B1 (en) 1999-12-30 2002-01-22 Alvin Kershman Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
CA2394290C (en) 1999-12-30 2006-08-29 Wm. Wrigley Jr. Company Release of lipophilic active agents from chewing gum
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6613346B2 (en) 2001-06-28 2003-09-02 Wm. Wrigley, Jr. Company Chewable product including active ingredient
US6763085B2 (en) 2001-10-22 2004-07-13 Cleaner Food, Inc. Irradiation apparatus and method
US6672252B2 (en) 2002-01-31 2004-01-06 Sergeant's Pet Products, Inc. Pet chew
WO2004014143A1 (en) * 2002-08-13 2004-02-19 Akzo Nobel Compositions and process for delivering an additive
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20040234579A1 (en) 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
DE10358534A1 (de) 2003-12-13 2005-07-14 Henkel Kgaa Adhäsionshemmung von Mikroorganismen durch nichtionische Tenside
WO2005094210A2 (en) 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US7318920B2 (en) 2004-09-27 2008-01-15 Ez-Med Company Low water activity nutritional product having beneficial microbial and high oil content
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US8114445B2 (en) 2008-11-07 2012-02-14 Reliv International Inc. Dietary supplement for promoting wellness and weight loss and methods of administering the same

Also Published As

Publication number Publication date
RU2519670C2 (ru) 2014-06-20
EP2656838A1 (en) 2013-10-30
ZA201105604B (en) 2013-03-27
US9381155B2 (en) 2016-07-05
CN101909605B (zh) 2013-07-24
CA2705724A1 (en) 2009-05-22
BRPI0820520A2 (pt) 2017-05-23
US8512787B2 (en) 2013-08-20
US8865240B2 (en) 2014-10-21
ZA201003245B (en) 2011-10-26
AU2008320992B2 (en) 2015-04-09
US7955632B2 (en) 2011-06-07
US20110223234A1 (en) 2011-09-15
US20120141574A1 (en) 2012-06-07
JP2011503197A (ja) 2011-01-27
EP2219626A1 (en) 2010-08-25
US20080075759A1 (en) 2008-03-27
BRPI0820520B1 (pt) 2020-10-06
EP2219626A4 (en) 2012-11-21
US20130331348A1 (en) 2013-12-12
AU2008320992A1 (en) 2009-05-22
AU2015203843B2 (en) 2018-05-31
AU2018223006A1 (en) 2018-09-20
US8114455B2 (en) 2012-02-14
AU2015203843A1 (en) 2015-07-30
WO2009064859A1 (en) 2009-05-22
CN101909605A (zh) 2010-12-08
CA2705724C (en) 2016-04-05
RU2010123868A (ru) 2011-12-20
US20150224052A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
EP2219626A4 (en) METHOD FOR MANUFACTURING DOSAGE FORMS FOR THE DELIVERY OF MEDICAMENTS AND PRODUCTS CONTAINING SAME
WO2007067582A3 (en) Process for manufacturing chewable dosage forms for drug delivery and products thereof
UY28757A1 (es) Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos
UY30373A1 (es) Derivados de fenilalanina, procedimientos de preparacion y aplicaciones
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
UY28271A1 (es) Compuestos químicos
ECSP088102A (es) Compuestos para el tratamiento de infecciones bacterianas resistentes a múltiples fármacos
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
ES2773883T3 (es) Nuevos comprimidos de meloxicam de baja concentración
AR062167A1 (es) Sistema de administracion gastrorretentivo
NZ631100A (en) Soft chewable pharmaceutical products
AR053680A1 (es) Composicion
JP2019501108A5 (pt)
UA101903C2 (ru) Лекарственное средство на основе дииндолилметана для лечения гиперпластических и воспалительных заболеваний
CN106999421A (zh) 适口的可咀嚼兽用组合物
WO2006105173A3 (en) Oral delivery vehicle and material
ES2925861T3 (es) Composiciones y formulaciones a base de estroncio para dolor, prurito e inflamación
IL251413B1 (en) Composition of injectable buprenorphine
EA201270615A1 (ru) Противогрибковый препарат, содержащий грибковый организм
UY28366A1 (es) Compuestos químicos
BR112014018096A2 (pt) péletes compreendendo amido e proteína, processo para obtenção destes e uso dos mesmos
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
FI3551166T3 (fi) Topikaalinen fenytoiini perifeerisen neuropaattisen kivun hoitoon
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/11/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2854 DE 16-09-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.